These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2423796

  • 41. Alpha-adrenergic blockade in severe asthma.
    Utting JA.
    Br J Dis Chest; 1979 Jul; 73(3):317-8. PubMed ID: 45254
    [Abstract] [Full Text] [Related]

  • 42. Antianginal and haemodynamic effects of alpha 1-adrenoceptor blockade.
    Sheridan DJ, Thomas P, Culling W, Collins P.
    J Cardiovasc Pharmacol; 1986 Jul; 8 Suppl 2():S144-50. PubMed ID: 2423788
    [Abstract] [Full Text] [Related]

  • 43. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP, O'Connor PC, Harron DW, Leahey WJ, Shanks RG.
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [Abstract] [Full Text] [Related]

  • 44. Possible use of indoramin in patients with chronic neurogenic bladder dysfunction.
    Vaidyanathan S, Rao MS, Sharma PL, Chary KS, Swamy RP.
    J Urol; 1983 Jan; 129(1):96-101. PubMed ID: 6827693
    [Abstract] [Full Text] [Related]

  • 45. [Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine].
    Pradalier A, Dry J, Loisy B, Meininger V, Vicaut E, Mirabaud C, Levy M.
    Therapie; 1988 Jan; 43(4):293-7. PubMed ID: 3055407
    [No Abstract] [Full Text] [Related]

  • 46. Effects of indoramin and metoprolol on plasma lipids and lipoproteins.
    Martinez TL, Auriemo CR, Machado AM, Cunha MA, Feres MC, Maldjian S, Wortsman A, Delboni FO.
    J Cardiovasc Pharmacol; 1986 Jan; 8 Suppl 2():S76-9. PubMed ID: 2423803
    [Abstract] [Full Text] [Related]

  • 47. Effect of indoramin on finger circulation in patients with Raynaud disease.
    Clement DL, Duprez D, De Pue N.
    J Cardiovasc Pharmacol; 1986 Jan; 8 Suppl 2():S84-7. PubMed ID: 2423806
    [Abstract] [Full Text] [Related]

  • 48. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP, McNeill J, O'Connor PC, Harron DW, Leahey WJ, Shanks RG.
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [Abstract] [Full Text] [Related]

  • 49. A trial of an alpha-adrenoreceptor blocking drug (indoramin) in exercise-induced bronchoconstriction.
    Seale JP, Anderson SD, Lindsay DA.
    Scand J Respir Dis; 1976 Aug; 57(6):261-6. PubMed ID: 189384
    [Abstract] [Full Text] [Related]

  • 50. The clinical pharmacology of indoramin.
    Shanks RG.
    J Cardiovasc Pharmacol; 1986 Aug; 8 Suppl 2():S8-15. PubMed ID: 2423804
    [No Abstract] [Full Text] [Related]

  • 51. Multicentre controlled trial of indoramin in the symptomatic relief of benign prostatic hypertrophy.
    Chow W, Hahn D, Sandhu D, Slaney P, Henshaw R, Das G, Wells P.
    Br J Urol; 1990 Jan; 65(1):36-8. PubMed ID: 1690068
    [Abstract] [Full Text] [Related]

  • 52. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
    Olivari MT, Garberg VR, Selby T, Cohn JN, Levine TB.
    Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
    [Abstract] [Full Text] [Related]

  • 53. Experience with terazosin administered in combination with other antihypertensive agents.
    Chrysant SG.
    Am J Med; 1986 May 23; 80(5B):55-61. PubMed ID: 2872808
    [Abstract] [Full Text] [Related]

  • 54. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan 23; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 55. [Indoramin in severe cardiac insufficiency. Acute hemodynamic effectiveness].
    Grube E, Lauven GW, Manz M, Lüderitz B.
    Dtsch Med Wochenschr; 1986 Mar 14; 111(11):416-20. PubMed ID: 3948703
    [Abstract] [Full Text] [Related]

  • 56. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
    Luther RR, Glassman HN, Estep CB, Schmitz PJ, Horton JK, Jordan DC.
    Am J Hypertens; 1988 Jul 14; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
    [Abstract] [Full Text] [Related]

  • 57. Preliminary observations of chronic indoramin therapy in congestive heart failure.
    Leier CV, Huss P, Parrish D, Binkley PF, Unverferth DV.
    J Cardiovasc Pharmacol; 1986 Jul 14; 8 Suppl 2():S112-6. PubMed ID: 2423783
    [Abstract] [Full Text] [Related]

  • 58. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
    Royds RB.
    Br J Pharmacol; 1972 Feb 14; 44(2):379P-380P. PubMed ID: 4668635
    [No Abstract] [Full Text] [Related]

  • 59. Indoramin: under pressure.
    Hopkins SJ.
    Nurs Mirror; 1982 Jan 06; 154(1):47. PubMed ID: 6915546
    [No Abstract] [Full Text] [Related]

  • 60. Letter: Indoramin in prevention of migraine.
    Wainscott G, Volans GN, Wilkinson M, Faux GA.
    Lancet; 1975 Jul 05; 2(7923):32-3. PubMed ID: 49624
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.